(1 - 23 von 28
)
B3C newswire
www.biotechnewswire.ai
AP — Jan Poth, Managing Director & CEO of SciRhom. „Today's news is a testament to the high-quality standards and joint efforts invested by ...
B3C newswire
www.biotechnewswire.ai
AP — Jan Poth, Managing Director & CEO of SciRhom, expressed his gratitude and pride in the development team's outstanding efforts, stating, "We ...
European Biotechnology Magazine
european-biotechnology.com
AP — ... Jan Poth, CEO, und Matthias Schneider, CSO. © SciRhom/ Paul Paulsen. Series A financing. SciRhom GmbH closes €63m Series A financing. German ...
FirstWord Pharma
firstwordpharma.com
AP — SR-878 is poised to enter clinical testing in the coming weeks. "We actually have all the necessary regulatory approvals," said CEO Jan Poth. " ...
sortiert nach Relevanz / Datum